1. Home
  2. VRA vs MDWD Comparison

VRA vs MDWD Comparison

Compare VRA & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

HOLD

Current Price

$2.21

Market Cap

60.6M

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$18.37

Market Cap

238.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRA
MDWD
Founded
1982
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Apparel
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.6M
238.5M
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
VRA
MDWD
Price
$2.21
$18.37
Analyst Decision
Buy
Strong Buy
Analyst Count
3
2
Target Price
$4.00
$37.50
AVG Volume (30 Days)
1.1M
83.5K
Earning Date
12-11-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$324,296,000.00
$20,932,000.00
Revenue This Year
N/A
$15.89
Revenue Next Year
$1.61
$25.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
6.15
52 Week Low
$1.39
$14.14
52 Week High
$4.09
$22.51

Technical Indicators

Market Signals
Indicator
VRA
MDWD
Relative Strength Index (RSI) 46.85 47.82
Support Level $2.25 $18.55
Resistance Level $2.50 $19.00
Average True Range (ATR) 0.18 0.55
MACD 0.01 -0.04
Stochastic Oscillator 71.49 6.62

Price Performance

Historical Comparison
VRA
MDWD

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: